Students from the LIU-iQ Consulting Program Attended Prestigious Global Conference
In January, twelve students in the LIU-iQ Consulting Program went to Brazil to present the results of their fall semester projects and learn about...
Student Recognized by New York Academy of Medicine
The New York Academy of Medicine awarded Doctorate of Social Work candidate Millicent Harry for her presentation of her doctoral research, titled: “The Experiences...
Honors College Student Earns Prestigious Fellowship
The LIU Honors College and Conolly College of Liberal Arts & Sciences announced that Xonhane Medina has won the prestigious J.K. Watson Fellowship which...
Education Leader Appointed as Fine Arts Director
Laila Sales ’17 was chosen as the new director of fine, performing and culinary arts for the West Hempstead School District. Sales has an...
Baseball and Cheer Teams Promote Inclusion
The basketball team recently hosted The League of Yes, an organization committed to creating and sustaining basketball programs for people of all ages with...
Record Label President Speaks to Students at Roc Nation School
Jamie Krents, President of Verve, Verve Forecast, and Impulse! Records, spoke with students in the Artist Management course at the Roc Nation School of...
Tilles Teams with Lincoln Center to Host Jazz Fest
In collaboration with Jazz at Lincoln Center, Tilles Center for the Performing Arts hosted the inaugural Tilles Jazz Fest on the Post campus. The...
Model UN Team Wins Top Award at International Conference
LIU Model UN team received the Outstanding Position Paper award and two Outstanding Individual Delegation awards at the international conference held at the United...
Rolling Stone Features Young Guru on AI in Music
Rolling Stone featured the insights of Gimel “Young Guru” Keaton, Grammy Award-winning producer and Director of the Music Technology, Entrepreneurship & Production program at...
Weinand Named Chairman at Replimune Group
Dieter Weinand (MS ’87) was appointed Chairman of the Board of Directors at Replimune Group Inc. (REPL), a biotechnology company developing oncolytic immuno-gene therapies....